1163 related articles for article (PubMed ID: 23868944)
21. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
22. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
23. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
[TBL] [Abstract][Full Text] [Related]
24. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention.
Boden H; Ahmed TA; Velders MA; van der Hoeven BL; Hoogslag GE; Bootsma M; le Cessie S; Cobbaert CM; Delgado V; van der Laarse A; Schalij MJ
Am J Cardiol; 2013 May; 111(10):1387-93. PubMed ID: 23465094
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).
Greco C; Pelliccia F; Tanzilli G; Tinti MD; Salenzi P; Cicerchia C; Schiariti M; Franzoni F; Speziale G; Gallo P; Gaudio C
Am J Cardiol; 2013 Sep; 112(5):630-5. PubMed ID: 23711809
[TBL] [Abstract][Full Text] [Related]
27. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
Stone GW; Martin JL; de Boer MJ; Margheri M; Bramucci E; Blankenship JC; Metzger DC; Gibbons RJ; Lindsay BS; Weiner BH; Lansky AJ; Krucoff MW; Fahy M; Boscardin WJ;
Circ Cardiovasc Interv; 2009 Oct; 2(5):366-75. PubMed ID: 20031745
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment-Elevation Myocardial Infarction: The MIMI Study.
Belle L; Motreff P; Mangin L; Rangé G; Marcaggi X; Marie A; Ferrier N; Dubreuil O; Zemour G; Souteyrand G; Caussin C; Amabile N; Isaaz K; Dauphin R; Koning R; Robin C; Faurie B; Bonello L; Champin S; Delhaye C; Cuilleret F; Mewton N; Genty C; Viallon M; Bosson JL; Croisille P;
Circ Cardiovasc Interv; 2016 Mar; 9(3):e003388. PubMed ID: 26957418
[TBL] [Abstract][Full Text] [Related]
29. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
Ke D; Zhong W; Fan L; Chen L
Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
[TBL] [Abstract][Full Text] [Related]
30. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.
Lønborg J; Schoos MM; Kelbæk H; Holmvang L; Steinmetz J; Vejlstrup N; Jørgensen E; Helqvist S; Saunamäki K; Bøtker HE; Kim WY; Terkelsen CJ; Clemmensen P; Engstrøm T
Am Heart J; 2012 Oct; 164(4):538-46. PubMed ID: 23067912
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study.
Haeck JD; Koch KT; Bilodeau L; Van der Schaaf RJ; Henriques JP; Vis MM; Baan J; Van der Wal AC; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
JACC Cardiovasc Interv; 2009 Oct; 2(10):934-43. PubMed ID: 19850252
[TBL] [Abstract][Full Text] [Related]
32. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S
Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
[TBL] [Abstract][Full Text] [Related]
33. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
34. The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) trial improves outcomes.
Sanchez-Ross M; Oghlakian G; Maher J; Patel B; Mazza V; Hom D; Dhruva V; Langley D; Palmaro J; Ahmed S; Kaluski E; Klapholz M
JACC Cardiovasc Interv; 2011 Feb; 4(2):222-7. PubMed ID: 21349462
[TBL] [Abstract][Full Text] [Related]
35. No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.
Roos ST; Timmers L; Biesbroek PS; Nijveldt R; Kamp O; van Rossum AC; van Hout GP; Stella PR; Doevendans PA; Knaapen P; Velthuis BK; van Royen N; Voskuil M; Nap A; Appelman Y
Int J Cardiol; 2016 Oct; 220():809-14. PubMed ID: 27394978
[TBL] [Abstract][Full Text] [Related]
36. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
37. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
38. Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.
Lønborg J; Vejlstrup N; Kelbæk H; Nepper-Christensen L; Jørgensen E; Helqvist S; Holmvang L; Saunamäki K; Bøtker HE; Kim WY; Clemmensen P; Treiman M; Engstrøm T
Diabetes; 2014 Jul; 63(7):2474-85. PubMed ID: 24584550
[TBL] [Abstract][Full Text] [Related]
39. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
[TBL] [Abstract][Full Text] [Related]
40. Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.
Basnet S; Kozikowski A; Makaryus AN; Pekmezaris R; Zeltser R; Akerman M; Lesser M; Wolf-Klein G
J Am Heart Assoc; 2015 Oct; 4(10):e002314. PubMed ID: 26494519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
